Wire · opportunities

FDA Approves First Once-Weekly Insulin for Type 2 Diabetes Mellitus in Pediatric Patients

23 October 2026 · By Derek Watson · Wire by Fusion42

Published

23 October 2026

Topic

opportunities

◆ Sectors

Drug Discovery

◆ Geography

United States

◆ Source

Read at fda.gov →

◆ Verified

Fusion42 · 24 October 2026 · Fusion42 review

The FDA has approved Awiqli, the first once-weekly insulin injection for pediatric patients aged 10 years and older with type 2 diabetes mellitus, improving glycemic control alongside diet and exercise.

This Wire brief sits within Fusion42's coverage of Drug Discovery, and 3 sources have reported it.

◆ ◆ The Wire takeaway

This approval opens the paediatric diabetes care market to new once-weekly insulin treatments, giving you an opportunity to innovate dosing convenience or support services distinct from daily insulin regimes.

◆ Coverage

3 sources · 23 Oct 2026

◆ Related on Wire

◆ Topics

Drug Discoveryfda-approvalinsulinpediatric-diabetestype-2-diabeteslong-acting-insulin